Insider Transactions in Q1 2026 at Axsome Therapeutics, Inc. (AXSM)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2026
|
Nick Pizzie Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12,000
-21.98%
|
$2,244,000
$187.92 P/Share
|
|
Jan 22
2026
|
Nick Pizzie Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+18.02%
|
$36,000
$3.5 P/Share
|
|
Jan 21
2026
|
Ari Maizel Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-100.0%
|
$1,380,000
$184.44 P/Share
|
|
Jan 21
2026
|
Ari Maizel Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$525,000
$70.73 P/Share
|
|
Jan 07
2026
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
31,261
-81.22%
|
$5,314,370
$170.38 P/Share
|
|
Jan 07
2026
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,261
+44.82%
|
$250,088
$8.02 P/Share
|
|
Jan 06
2026
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,450
-80.29%
|
$5,065,400
$172.33 P/Share
|
|
Jan 06
2026
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,450
+44.53%
|
$235,600
$8.02 P/Share
|
|
Jan 05
2026
|
Herriot Tabuteau Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
78,703
-91.59%
|
$13,458,213
$171.28 P/Share
|
|
Jan 05
2026
|
Herriot Tabuteau Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
78,703
+47.8%
|
$629,624
$8.02 P/Share
|